Bank of America
EWTX icon

Bank of America’s Edgewise Therapeutics EWTX Stock Holding History

Bank of America’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$63.3M Buy
1,558,260
+230,900
+17% +$7.96M ﹤0.01% 1517
2026
Q1 		$41.8M Sell
1,327,360
-147,437
-10% -$4.25M ﹤0.01% 1730
2025
Q4 		$36.6M Buy
1,474,797
+1,153,665
+359% +$23.2M ﹤0.01% 1776
2025
Q3 		$5.21M Buy
321,132
+66,703
+26% +$946K ﹤0.01% 3971
2025
Q2 		$3.34M Sell
254,429
-440,997
-63% -$6.36M ﹤0.01% 4299
2025
Q1 		$15.3M Buy
695,426
+646,519
+1,322% +$17M ﹤0.01% 2736
2024
Q4 		$1.31M Sell
48,907
-259,144
-84% -$8.25M ﹤0.01% 4802
2024
Q3 		$8.22M Buy
308,051
+35,257
+13% +$701K ﹤0.01% 3254
2024
Q2 		$4.91M Buy
272,794
+219,031
+407% +$3.82M ﹤0.01% 3642
2024
Q1 		$981K Sell
53,763
-8,505
-14% -$135K ﹤0.01% 4947
2023
Q4 		$681K Buy
62,268
+21,042
+51% +$148K ﹤0.01% 5280
2023
Q3 		$236K Sell
41,226
-11,075
-21% -$75.3K ﹤0.01% 5803
2023
Q2 		$405K Sell
52,301
-2,272
-4% -$19.2K ﹤0.01% 5421
2023
Q1 		$364K Buy
54,573
+1,993
+4% +$18.5K ﹤0.01% 5579
2022
Q4 		$470K Buy
52,580
+39,347
+297% +$369K ﹤0.01% 5425
2022
Q3 		$130K Sell
13,233
-26,685
-67% -$270K ﹤0.01% 6215
2022
Q2 		$318K Buy
39,918
+12,368
+45% +$93.5K ﹤0.01% 5756
2022
Q1 		$267K Sell
27,550
-1,236
-4% -$15.9K ﹤0.01% 6281
2021
Q4 		$440K Buy
28,786
+26,046
+951% +$469K ﹤0.01% 5988
2021
Q3 		$46K Buy
+2,740
New +$49.6K ﹤0.01% 7087

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America's EWTX Position: Q2 2026 in Review

Bank of America increased its Edgewise Therapeutics (EWTX) stake by 17% in Q2 2026, buying an estimated $7.96M and bringing the position to 1,558,260 shares worth $63.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1517.

Bank of America first reported a position in EWTX in Q3 2021 and has held it in 20 quarters since. 223 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Bank of America held 1,558,260 shares of Edgewise Therapeutics worth $63.3M as of Q2 2026.
  • Bank of America bought 230,900 Edgewise Therapeutics shares in Q2 2026, an estimated $7.96M.
  • Edgewise Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #1517 holding.
  • Bank of America first reported a position in Edgewise Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • 223 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.